Pharvaris N.V.
(PHVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 384,902 | 226,554 | 249,149 | 303,776 | 335,590 |
| Receivables | 3,433 | 2,948 | 2,785 | 3,186 | 3,002 |
| Other current assets | 5,803 | 6,817 | 7,418 | 6,219 | 4,787 |
| TOTAL | $394,138 | $236,319 | $259,352 | $313,181 | $343,380 |
| Non-Current Assets | |||||
| PPE Net | 807 | 817 | 827 | 722 | 597 |
| Other Non-Current Assets | 1,191 | 1,040 | 1,157 | 1,394 | 391 |
| TOTAL | $1,998 | $1,858 | $1,984 | $2,116 | $988 |
| Total Assets | $396,136 | $238,177 | $261,336 | $315,297 | $344,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,978 | 5,516 | 4,452 | 4,938 | 4,614 |
| Accrued Expenses | 26,510 | 22,023 | 18,082 | 19,032 | 13,278 |
| TOTAL | $30,642 | $28,382 | $23,365 | $24,861 | $18,002 |
| Non-Current Liabilities | |||||
| TOTAL | $516 | $537 | $576 | $692 | $19 |
| Total Liabilities | $31,158 | $28,919 | $23,941 | $25,553 | $18,021 |
| Shareholders' Equity | |||||
| Common Shares | 9,112 | 7,457 | 6,889 | 7,061 | 7,156 |
| Retained earnings | -622,294 | -561,861 | -472,711 | -435,280 | -403,278 |
| Other shareholders' equity | 55,298 | 49,991 | 45,386 | 43,121 | 39,705 |
| TOTAL | $364,978 | $209,258 | $237,395 | $289,744 | $326,347 |
| Total Liabilities And Equity | $396,136 | $238,177 | $261,336 | $315,297 | $344,368 |